Unbalanced osteoclast mediated bone resorption is major cause of osteoporosis. Significant progress has been made recently in studies of the mechanism by which RANKL induces osteoclast terminal differentiation. However, how RANKL signal evokes [Ca2+]i oscillation that lead osteoclast differentiation thought NFAT2 pathway still remain unclear. It has been reported that Regulator of G-protein Signaling Protein (RGS) is responsible to [Ca2+]i oscillation regulation in many other tissues and cells. Using differential screening, we found that Regulator of G-protein Signaling Protein 10 gene (RGS10) was predominately expressed in RANKL-induced osteoclast-like cells (OLCs). This result was further confirmed at both mRNA and protein level in both mouse and human osteocalsts. Knockdown of RGS10 expression using RNA interference (RNAi) nhibited osteoclast terminal differentiation induced by RANKL. Our data demonstrated that the failure of osteoclast terminal differentiation resulted from the absence of [Ca2+]i oscillations and silence of NFAT2 expression. Based our results, We hypothesize that RGS10 is essential and sufficient to induce the calcium oscillations for terminal differentiation of osteoclasts. We will test this hypothesis through three specific aims. First, We will examine the spatial and temporal expression of RGS10 and determine whether RGS10 itself directly cause the calcium oscillations for osteoclast differentiation and the functional role of RGS10 in mature osteoclast survival and activation.
In Aim 2, we will define the RGS10 role in bone remodeling and osteoclast differentiation by targeted disruption of RGS10 gene and characterization of the phenotypes of RGS10 knockout mice. The effect of the null mutation on pre-osteoclast proliferation, prosteoclast calcium oscillations, osteoclast differentiation, activation and gene regulation in vivo will be determined. Finally, we will identify the mechanism of RGS10 acting in osteoclast differentiation by characterization of RGS10 heterodimerzation partners and the partners functions. The heterodimerzation partners will be characterized by the approaches of yeast two-hybrid system and co-immunoperticipation. The function of the heterodimerzation partners will be characterized using RNAi approach. RGS10 role in G-protein singling will be characterized. The overall goal of these studies is to establish the roles of RGS10 in osteoclast differentiation and function and discover the mechanism underlying how RANKL signal evokes [Ca2+]i oscillation that lead osteoclast differentiation, and to ultimately apply this knowledge to the control of osteolytic diseases.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
Skeletal Biology Structure and Regeneration Study Section (SBSR)
Program Officer
Chen, Faye H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Alabama Birmingham
Schools of Medicine
United States
Zip Code
McConnell, Matthew; Feng, Shengmei; Chen, Wei et al. (2017) Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity. Oncotarget 8:47675-47690
Wu, Mengrui; Wang, Yiping; Shao, Jian-Zhong et al. (2017) Cbf? governs osteoblast-adipocyte lineage commitment through enhancing ?-catenin signaling and suppressing adipogenesis gene expression. Proc Natl Acad Sci U S A 114:10119-10124
Jules, Joel; Chen, Wei; Feng, Xu et al. (2016) CCAAT/Enhancer-binding Protein ? (C/EBP?) Is Important for Osteoclast Differentiation and Activity. J Biol Chem 291:16390-403
Wu, Mengrui; Chen, Guiqian; Li, Yi-Ping (2016) TGF-? and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res 4:16009
Li, Sheng; Hao, Liang; Wang, Lin et al. (2015) Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology. PLoS One 10:e0134903
Jules, Joel; Yang, Shuying; Chen, Wei et al. (2015) Role of Regulators of G Protein Signaling Proteins in Bone Physiology and Pathophysiology. Prog Mol Biol Transl Sci 133:47-75
Hao, Liang; Zhu, Guochun; Lu, Yun et al. (2015) Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role. FEBS Lett 589:1331-1339
Zhu, Zheng; Chen, Wei; Hao, Liang et al. (2015) Ac45 silencing mediated by AAV-sh-Ac45-RNAi prevents both bone loss and inflammation caused by periodontitis. J Clin Periodontol 42:599-608
Wang, Yiping; Li, Yi-Ping; Paulson, Christie et al. (2014) Wnt and the Wnt signaling pathway in bone development and disease. Front Biosci (Landmark Ed) 19:379-407
Tian, Fei; Wu, Mengrui; Deng, Lianfu et al. (2014) Core binding factor beta (Cbf?) controls the balance of chondrocyte proliferation and differentiation by upregulating Indian hedgehog (Ihh) expression and inhibiting parathyroid hormone-related protein receptor (PPR) expression in postnatal cartilage and J Bone Miner Res 29:1564-1574

Showing the most recent 10 out of 45 publications